Metagenomi

Biotechnology company founded in 2018 in Berkeley, California. Metagenomi develops next-generation gene-editing tools sourced from natural microbial diversity. Its platform discovers and engineers new CRISPR systems and nucleases for therapeutic use, aiming at safer and more versatile genome editing. Backed by Leaps by Bayer and other major investors, with partnerships in cell and gene therapy. (m...